Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086775
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2004-07-08
Brief Title:
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Sponsor:
Bayer
Organization:
National Cancer Institute NCI